November 05, 2020
BioPharmGuy News
The DASbox is a unique mini bioreactor system suitable for microbial and cell culture applications including stem cells. It is designed as a 4-fold system with up to twenty-four parallel operating bioreactors. With working volumes of 60 – 250 mL the DASbox is the optimal tool for advanced process development. All critical process parameters can be precisely controlled. 
Visit our website!

Visit their website for more information.
BioPharmGuy

Hello everyone. Hope you've caught your breath a bit these past couple days. We are trying to get back on track after yesterday's total waste of a day. Seriously, who gives an 8-hour window for a dishwasher delivery anyways? Wasted a whole day on that and definitely not on checking CNN nonstop.

Unnecessary Page of the Week
Company called SteroTherapeutics has a menu item atop their website for "Investor Relations" over which you can hover and the dropdown shows "Stock Information". Very normal thing to see. Except in this case when you click that Stock Information link, you are informed of the following: "SteroTherapeutics is currently a privately held company. No stock information is available at this time." What. The. Hell.

Addition & Attrition
11 added, 37 removed. You read that right - we did our monthly cull a couple weeks late, so there were a lot of companies with busted websites to remove. Summary file on our downloads page. Didn't quite finish getting through last week's news, so the monthly funding summary will come along next week. Sorry! (not really)
Industry
Novellus Therapeutics
These guys changed their url and launched a new website. In doing so, they added icons for their menu items. What icon did they choose for their drug pipeline page? An actual piece of pipe. No points for imagination, but can't really fault them.

EQRx
Just paid $150M for a prospective drug after getting funded with $200M in January. Their big coming out party in January was wrapped up in the fact that they would have 10 drugs approved in 10 years and they would be sold cheaply. That was crazy then and it seems even crazier now. If we read this right, their execution strategy is:

-get investor money
-sit on it for nine months while getting paid a salary
-buy a potential drug for which there are many existing competitors
-charge less
-profit?

Yeah, right. There are all sorts of zany investments out there in biotech right now, but investing in a company focusing on low-margin, high-competition markets is about as foolish as you could possibly come up with. #NotMyMoney

Asedas Sciences
We first recorded this company's website as being down in August. They now have a countdown to re-launch going - midnight on November 15 is the anointed moment. For a company to be that confident in a relaunch moment after having a website totally offline for months is kinda funny.

Anyways, not sure what the point of all this is - you're supposed to design a new website and when it's finished you just replace the old with the new which comes with basically zero downtime.

And yet who among us can now say they aren't totally hyped for November 15th, 2020?
Health & Science
Covid Antibodies
The experimental Covid-19 antibody treatments from Regeneron & Eli Lilly seem to be showing a decrease in viral load and doctor visits, but no survival benefit for hospitalized patients. That's nice, but for how expensive these products are, more tangible health outcomes normally need to be demonstrated.

High on Crystal(s)
There have been some really bad 'scientific' publications related to Covid-19. Like, really bad. Remember the one about a meteorite strike thousands of miles from Wuhan that was suggested to have brought the virus to Earth? Well, we have another doozy here:

"Can Traditional Chinese Medicine provide insights into controlling the COVID-19 pandemic: Serpentinization-induced lithospheric long-wavelength magnetic anomalies in Proterozoic bedrocks in a weakened geomagnetic field mediate the aberrant transformation of biogenic molecules in COVID-19 via magnetic catalysis"

That title went straight from health-ish to geology...which is not a good sign when every author is in the department of infectious diseases. The authors ultimately propose that Nephrite-Jade crystal amulets may prevent Covid-19. 

As always, only the finest work from whatever no-name overseas university these people work at...what's that? They all work at the University of Pittsburgh? Oooh boy. The lead author confirmed he did indeed submit this and the publication's editor confirmed it was "peer-reviewed" by two people. Unbelievable. Someone's tenure clock must be running out fast.

Feral Wallabies
Britain seems to have a small population of feral wallabies. 95 confirmed sightings have been mapped for all you wallaby-chasers over there. BioPharmGuy saw a couple eating a pumpkin at the local zoo a couple weeks ago. No chase needed.
Subscribe
If you were forwarded this email and would like to join our mailing list, here's our sign-up page: https://biopharmguy.com/subscribe.php
Premium Listings Always Available
Promote your Company's Listing
Check your website analytics - we are likely one of your top referrers. You can quickly double those referrals with a Premium Listing. Try it for as short as one month. Full summary of all our upgrade options available here: Promoted Listings. Reply to this email or send a message if interested.